Biotech stocks have been hit hard — here are ones analysts like best for a rebound
November 08, 2018 at 05:32 AM EST
Nine companies have majority ‘buy’ ratings, with upside potential of as much as 123%, according to analysts.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|